Publications

Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, Cristofanilli M. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res. 2008 Mar 15;14(6):1718-25. [abstract]

Dawood S, Broglio K, Gong Y, Yang WT, Cristofanilli M, Meric Bernstam F, Buchholz TA, Hotrobagyi GN, Gonzales Angulo AM. Prognostic significance of HER2 status in women with inflammatory breast cancer. Cancer. [abstract]

Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Tereffe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Local-regional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. In press. [abstract]

Le-Petross CH, Bidaut L, Yang WT. Evolving role of imaging modalities in inflammatory breast cancer. Semin Oncol. 2008 Feb;35(1):51-63. [abstract]

Gong Y. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype. Semin Oncol. 2008 Feb;35(1):33-40. [abstract]

Resetkova E. Pathologic aspects of inflammatory breast carcinoma: Part 1. Histomorphology and differential diagnosis. Semin Oncol. 2008 Feb;35(1):25-32. [abstract]

Woodward WA, Buchholz TA. The role of locoregional therapy in inflammatory breast cancer. Semin Oncol. 2008 Feb;35(1):78-86. [abstract]

Mazouni C, Hall A, Broglio K, Fritsche H, Andre F, Esteva FJ, Hortobagyi GN, Buzdar AU, Pusztai L, Cristofanilli M. Kinetics of serum HER-2/neu changes in patients with HER-2 positive primary breast cancer after initiation of primary chemotherapy. Cancer 2007;109(3):496-501. [abstract]

Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, Krishnamurthy S, Ueno NT, Hortobagyi GN, Valero V. Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden. Clin Breast Cancer 2007;7(6):471-479.  [abstract]

Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 2007;13(3):920-8. [abstract]

Dawood S, Cristofanilli M. Endocrine resistance in breast cancer: What really matters? Ann Oncol 2007;18(8):1289-1291. [abstract]

Cabioglu N, Gong Y, Broglio K, Islam R, Sneige N, Sahin A, Gonzalez-Angulo AM, Morandi P, Bucana C, Hortobagyi GN, Cristofanilli M. Expression of growth factors and chemokine receptors: New insights in the biology of inflammatory breast cancer. Ann Oncol 2007;18(6):1021-1029. [abstract]

Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN. Trends for inflammatory breast cancer: Is survival improving? Oncologist 2007;12(8):904-912. [abstract]

Dawood S, Cristofanilli M. What progress have we made in managing inflammatory breast cancer? Oncology 2007;21(6):673-9. [abstract]

Cristofanilli M, Valero V, Buzdar U, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R, Ueno NT, Buchholz TA, Singletary SE, Hortobagyi GN. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease. Cancer 2007;110(7):1436-1444. [abstract]

Bristol IJ, Buchholz TA. Inflammatory breast cancer: current concepts in local management. Breast Dis 2007;22:75-83. [abstract]

Yang CH, Cristofanilli M. Systemic treatments for inflammatory breast cancer. Breast Dis 2007;22:55-65. [abstract]

Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M. Inflammatory breast cancer - PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2007 Jul 26; [Epub ahead of print]. [abstract]

Currently in Submission

Reuben JM, Lee BN, Li C, Gao H, Broglio KR, Valero V, Jackson SA, Ueno NT, Krishnamurthy S, Hortobagyi GN, Cristofanilli M. Circulating tumor cells (CTCs) and biomarkers expression: Implications for personalized treatments for metastatic breast cancer. In submission. Lancet Oncology.

Robertson FM, Woodward WA, Reuben JM, McMurray J, Lucci A, Simeone, A-M, Cristofanilli M. 2008. Regulation of Proliferation and Invasion of Inflammatory Breast Cancer by the EP4 Receptor. In submission. Cancer Research.

Carkaci S, Macapinlac H, Cristofanilli M, Gonzalez-Angullo A, Resetkova E, Le-Petross H, Yang WT. The role of FDG-PET/CT in the staging of inflammatory breast cancer. In submission. Radiology.